International Stem Cell (OTCMKTS:ISCO) Shares Cross Above 200 Day Moving Average – What’s Next?

International Stem Cell Corp. (OTCMKTS:ISCO)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.15 and traded as high as $0.17. International Stem Cell shares last traded at $0.17, with a volume of 302 shares trading hands.

International Stem Cell Trading Up 6.3%

The firm has a market cap of $1.36 million, a price-to-earnings ratio of -8.50 and a beta of 0.13. The firm has a 50-day moving average of $0.15 and a two-hundred day moving average of $0.15.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.